DEXAMETHASONE PANPHARMA 4 mg/ml, solution for injection 10 ampoules of 1 ml
Active ingredients: Dexamethasone phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 1 mlinfiltration;intraarticulaire;intramusculaire;intraveineuse;sous-conjonctivale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEXAMETHASONE PANPHARMA 4 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intraarticulaire;intramusculaire;intraveineuse;sous-conjonctivale
- Presentation description
- 10 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Apr 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68973246CIP75507714CIP133400955077145Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE DE DEXAMÉTHASONEsolution | 4,0 mg · une ampoule de 1 mL de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.